Immunology of H7-H1 and its roles in human diseases

被引:30
作者
Tamura, H
Ogata, K
Dong, HD
Chen, LP
机构
[1] Nippon Med Coll, Dept Internal Med 3, Bunkyo Ku, Tokyo 1138603, Japan
[2] Mayo Clin, Dept Immunol, Rochester, MN USA
关键词
B7-H1; costimulation; immunosuppression; tumor; autoimmune diseases; T-CELL-ACTIVATION; B7; FAMILY; COSTIMULATORY MOLECULES; PD-1; B7-H1; EXPRESSION; RECEPTOR; ICOS; LIGANDS; MEMBER;
D O I
10.1007/BF02983556
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
B7-H1 was originally identified by homology analysis in comparison with B7-1 and B7-2, two molecules with important immunoregulatory functions. B7-H1, however, was broadly induced in the majority of peripheral tissues as well as hematopoietic cells. Upon binding to an as yet unidentified costimulatory receptor on primed T-cells, B7-H1 costimulates T-cell proliferation and preferentially induces interleukin 10 and interferon gamma. The costimulatory function of B7-H1 may be critical for enhancing maturation and differentiation of T-cells in lymphoid organs. Conversely, by binding to programmed death 1 receptors on activated T-cells and B-cells, B7-H1 may inhibit ongoing T-cell responses in peripheral tissues by inducing apoptosis and arresting cell-cycle progression. Although a positive regulatory role of B7-H1 has been demonstrated in vitro and in various animal models, a negative regulatory role of B7-H1 has also been documented in human diseases, including cancer, rheumatoid arthritis, and human immunodeficiency virus infection. Delineation of the complex interactions between B7-H1 and its receptors as well as its interplay with other ligands is critical for understanding this new immunoregulatory system. Precise manipulation of B7-H1 and its receptors may provide unique opportunities for designing new disease treatments. (C) 2003 The Japanese Society of Hematology.
引用
收藏
页码:321 / 328
页数:8
相关论文
共 54 条
  • [1] Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes
    Agata, Y
    Kawasaki, A
    Nishimura, H
    Ishida, Y
    Tsubata, T
    Yagita, H
    Honjo, T
    [J]. INTERNATIONAL IMMUNOLOGY, 1996, 8 (05) : 765 - 772
  • [2] Mechanisms of interleukin-10-mediated immune suppression
    Akdis, CA
    Blaser, K
    [J]. IMMUNOLOGY, 2001, 103 (02) : 131 - 136
  • [3] THE YIN AND YANG OF T-CELL COSTIMULATION
    ALLISON, JP
    KRUMMEL, MF
    [J]. SCIENCE, 1995, 270 (5238) : 932 - 933
  • [4] CD28 COSTIMULATION CAN PROMOTE T-CELL SURVIVAL BY ENHANCING THE EXPRESSION OF BCL-X(L)
    BOISE, LH
    MINN, AJ
    NOEL, PJ
    JUNE, CH
    ACCAVITTI, MA
    LINDSTEN, T
    THOMPSON, CB
    [J]. IMMUNITY, 1995, 3 (01) : 87 - 98
  • [5] Blockade of programmed death-1 Ligands on dendritic cells enhances T cell activation and cytokine production
    Brown, JA
    Dorfman, DM
    Ma, FR
    Sullivan, EL
    Munoz, O
    Wood, CR
    Greenfield, EA
    Freeman, GJ
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 170 (03) : 1257 - 1266
  • [6] Co-stimulation in T cell responses
    Chambers, CA
    Allison, JP
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (03) : 396 - 404
  • [7] B7-H3:: A costimulatory molecule for T cell activation and IFN-γ production
    Chapoval, AI
    Ni, J
    Lau, JS
    Wilcox, RA
    Flies, DB
    Liu, D
    Dong, HD
    Sica, GL
    Zhu, GF
    Tamada, K
    Chen, LP
    [J]. NATURE IMMUNOLOGY, 2001, 2 (03) : 269 - 274
  • [8] TUMOR IMMUNOGENICITY DETERMINES THE EFFECT OF B7 COSTIMULATION ON T-CELL-MEDIATED TUMOR-IMMUNITY
    CHEN, LP
    MCGOWAN, P
    ASHE, S
    JOHNSTON, J
    LI, YW
    HELLSTROM, I
    HELLSTROM, KE
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) : 523 - 532
  • [9] COSTIMULATION OF T-CELLS FOR TUMOR-IMMUNITY
    CHEN, LP
    LINSLEY, PS
    HELLSTROM, KE
    [J]. IMMUNOLOGY TODAY, 1993, 14 (10): : 483 - 486
  • [10] CHEN LP, 1994, CANCER RES, V54, P5420